Eone Diagnomics Genome Center Co., Ltd. announced a private placement to issue Series 11 Bearer-Type Non-Guaranteed Private Convertible Bonds for the gross proceeds of KRW 20,000,000,000 on March 22, 2024. The transaction will include participation from Kringtech Co., Ltd. The transaction has been approved by shareholders of company and is expected to close on April 4, 2024. The bonds are 100% convertible into 37,664,783 shares at a fixed conversion price of KRW 531 from April 4, 2025 to March 4, 2029.

The bonds bear zero coupon rate and zero maturity rate and matures on April 4, 2029.